Figure 2
From: Identification of PCA3 (DD3) in prostatic carcinoma by in situ hybridization
ISH followed by radioactive detection. (a) Malignant and normal glands; (b) malignant glands and (c) HGPIN.
Figure 2 | Modern Pathology
From: Identification of PCA3 (DD3) in prostatic carcinoma by in situ hybridization
ISH followed by radioactive detection. (a) Malignant and normal glands; (b) malignant glands and (c) HGPIN.
